The Current State of 340B and What to Expect in 2023 | Quarles & Brady LLP
2022 was an eventful year on the 340B front, packed with updates to consequential litigation, proposed new rules, ongoing uncertainty into the Health Resources and Services...
United States America Ph Eli Lilly Health Resources Drug Price Negotiation Program Us District Court
Source: jdsupra.com